Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

BMS Announces High Cure Rates for Hepatitis C Drug

November 10, 2014 10:42 am | News | Comments

Bristol-Myers Squibb announced late-breaking data regarding a new drug combination for Hepatitis C patients. Read more...                       

TOPICS:

Ebola Volunteers Wrestle With Quarantine Mandates

November 10, 2014 9:19 am | by Jennifer Peltz - Associated Press | News | Comments

As Ebola-related quarantine policies have arisen around the United States, some health workers are reassessing whether, or how long, they can be among the hundreds that officials said are needed to fight the outbreak. Read more...     

TOPICS:

New Breakthrough Could Halt The Spread of Prostate Cancer

November 10, 2014 9:10 am | News | Comments

Scientists believe a new treatment could halt the growth of tumors in patients with prostate cancer. Read more...                         

TOPICS:
Advertisement

Why Placebos for Chemotherapy Side Effects Are Hard to Swallow

November 10, 2014 8:55 am | by Nial Wheate and Betty Chaar, University of Sydney | News | Comments

Recent research shows placebos are just as effective as prescribed medicines for treating emergency room patients with nausea. Read more...                    

TOPICS:

Not to be Missed This Week: Journal Watch

November 7, 2014 4:48 pm | by Drug Discovery & Development Staff | Articles | Comments

Our editors searched for trending topics from leading scientific journals that will have you talking at the water cooler and sending them out via social media to friends and colleagues. Read more...               

TOPICS:

Lycera's Oral Immunotherapy May Have Anti-Cancer Activity

November 7, 2014 1:13 pm | News | Comments

Lycera Corp., a biopharmaceutical company developing breakthrough oral immune modulators to treat autoimmune disease and cancer, announced that data on the anti-tumor activity of the company’s novel synthetic RORgamma agonist product candidates were presented at the Society for Immunotherapy of Cancer (SITC) annual meeting being held in National Harbor, MD. Read more...

TOPICS:

Newly Developed Vaccines Could Reveal Asthma Clues

November 7, 2014 1:08 pm | by Rob Forman - Rutgers Universtiy | News | Comments

A new method of developing vaccines could point the way forward in the fight against infectious diseases for which traditional vaccination has failed, according to a Rutgers study.  Read more...

TOPICS:

New Vaccine Generates Strong Immune Response Against Hep C

November 7, 2014 1:01 pm | by University of Oxford | News | Comments

A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University, generating strong and broad immune responses against the virus causing the disease. Read more...

TOPICS:
Advertisement

New Drug for Common Liver Disease May Improve Liver Health

November 7, 2014 12:52 pm | News | Comments

An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health.  Read more...

TOPICS:

FDA Approves Lilly's Gastric Cancer Drug

November 7, 2014 12:46 pm | News | Comments

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Cryamza (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach). Read more...

TOPICS:

Mylan Launches Generic Loestrin 24 Fe

November 7, 2014 12:41 pm | News | Comments

Mylan Inc. announced the U.S. launch of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate, which is the generic version of Warner Chilcott's Loestrin 24 Fe. Read more...

TOPICS:

Felicitex To Collaborate On Breakthrough Cancer Therapy

November 7, 2014 10:38 am | News | Comments

Felicitex Therapeutics and Selvita announce a strategic collaboration for personalized cancer therapeutics for some of the deadliest and most resistant cancers. Read more...               

TOPICS:

Cardiome's AFib Drug Receives Positive Results

November 7, 2014 10:28 am | News | Comments

Cardiome announced positive results for its atrial fibrillation drug in the Asia Pacific region. Read more...                          

TOPICS:

Experts Welcome Guidance on Take-Home Opiate Antidote

November 7, 2014 10:16 am | News | Comments

Experts welcome guidance recommending that patients, families and other non-medics who may come into contact with heroin addicts should carry an antidote for opiate overdose. Read more...            

TOPICS:

Paul Allen to Donate Millions for Ebola Relief

November 7, 2014 9:56 am | News | Comments

Philanthropist Paul G. Allen announced new grants to provide immediate humanitarian relief to address basic human needs that are being threatened by the Ebola outbreak in West Africa. Read more...           

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading